FOLI BIO INC.

Medtech · Private

Stool-based molecular diagnostic platform for real-time gut health monitoring and IBD biomarker detection

Grants
$597K
2 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · Non-invasive exfoliome platform to accelerate treatment for gastrointestinal disorders$292,375
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Development of a High-Throughput Fecal Exfoliome Analyzing Platform for Clinical Drug Development$305,000
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2093VDF INDUSTRIES INC——
2094Cognext Diagnostics LLC——
2095AURICLE HEALTH INC——
2096FOLI BIO INC.——
2097InseRT——
2098Monogram Orthopaedics Inc.——
2099GEL4MED, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.